Enveric Biosciences Inc. (ENVB) stock soars during pre-market. Let’s find out why?
Enveric Biosciences Inc. (NASDAQ: ENVB) stock showed a gain of 11.47% at last close while it further rises in pre-market by 12.76%. Enveric Biosciences is a patient-centered biotechnology organization focused on creating innovative cannabinoid medicines that increase cancer patients’ quality of life. Radiodermatitis, a frequent and sometimes serious side effect of radiation therapy, and chemotherapy-induced […]